SCHEMBL4543604

SCHEMBL4543604

CS(=O)(=O)c1ccc(NNC(=O)c2cccn2-c2ncc(C(F)(F)F)cc2Cl)c(F)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.64
CYP3A4 P08684 1/20 0.64
CYP2C9 P11712 1/20 0.64
CYP2C19 P33261 1/20 0.64
MAPT P10636 6/20 0.54
NPSR1 Q6W5P4 4/20 0.54
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
PPARG P37231 1/20 0.52
NR2E3 Q9Y5X4 1/20 0.52
NCOR2 Q9Y618 1/20 0.52
ALDH1A1 P00352 5/20 0.50
PKM P14618 2/20 0.47
LMNA P02545 2/20 0.44
SMN1; SMN2 Q16637 3/20 0.42
POLB P06746 2/20 0.41
NPY1R P25929 1/20 0.41
NPY2R P49146 1/20 0.41
SLC6A9 P48067 1/20 0.41
KCNH2 Q12809 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4537581 0.88 MAPT (0.62) CYP1A2CYP3A4CYP2C9CYP2C19MAPT
SCHEMBL13707610 0.88 CYP1A2 (0.82) CYP1A2CYP3A4CYP2C9CYP2C19MAPT
SCHEMBL4540161 0.88 CYP1A2 (0.70) CYP1A2CYP3A4CYP2C9CYP2C19MAPT
SCHEMBL4543922 0.86 MAPT (0.51) CYP1A2CYP3A4CYP2C9CYP2C19MAPT
SCHEMBL4543904 0.86 CYP1A2 (0.67) CYP1A2CYP3A4CYP2C9CYP2C19MAPT
SCHEMBL4542241 0.84 MEN1 (0.62) CYP1A2CYP3A4CYP2C9CYP2C19MAPT
SCHEMBL4544054 0.84 CYP1A2 (0.67) CYP1A2CYP3A4CYP2C9CYP2C19MAPT
SCHEMBL4542858 0.83 SMN1; SMN2 (0.52) CYP1A2CYP3A4CYP2C9CYP2C19MAPT
SCHEMBL13707606 0.82 CYP1A2 (0.73) CYP1A2CYP3A4CYP2C9CYP2C19MAPT
SCHEMBL4543841 0.82 CYP1A2 (0.64) CYP1A2CYP3A4CYP2C9CYP2C19MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009117421-A2 HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE KALYPSYS, INC. (US) 2009-09-24 WO disclosed
WO-2009117421-A2 HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE KALYPSYS, INC. (US) 2009-09-24 WO disclosed